MITOTAX PACLITAXEL INJECTION

Get a Price/Quote

MITOTAX PACLITAXEL INJECTION Specification

Pacakaging (Quantity Per Box)
One vial

Origin of Medicine
Allopathic

Indication
Ovarian cancer, breast cancer, non-small cell lung cancer, Kaposis sarcoma

Dosage Form
Injection

Salt Composition
Paclitaxel

Drug Type
Cytotoxic, prescription only

Ingredients
Paclitaxel

Physical Form
Injection

Function

Recommended For
Cancer treatment (including ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposis sarcoma)

Dosage
As directed by physician

Dosage Guidelines
Intravenous infusion, dosage varies according to indication

Suitable For
Adults

Quantity
One vial per box

Storage Instructions
Store at 20C to 25C (68F to 77F), protected from light

Contraindications
Hypersensitivity to paclitaxel or formulation components

Brand Name
MITOTAX

Route of Administration
Intravenous

Warning/Precaution
Administer under supervision of oncology specialist

Strength
100 mg/16.7 ml

Shelf Life
24 months from date of manufacture

Frequency of Dosage
Once every 1 or 3 weeks depending on indication

Side Effects
Nausea, vomiting, alopecia, myelosuppression, peripheral neuropathy

Manufactured By
Zydus

Prescription Status
Prescription required

Marketed By
Zydus Healthcare Ltd.

Appearance
Clear, colorless to pale yellow solution

MITOTAX PACLITAXEL INJECTION Trade Information

Packaging Details
PACK 50 MLVIAL

Main Domestic Market
All India

About MITOTAX PACLITAXEL INJECTION

Mitotax-300 Injection

Specifications:-

Brand Name: MITOTAX
Content: Paclitaxel
Strengths: 300 mg/ 5 ml
Form : Injection
Packing: pack of 50 ml vial
Manufactured By: Dr.Reddys

Note :-MITOTAX Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............

Targeted Chemotherapy for Multiple Cancers

MITOTAX Paclitaxel Injection provides effective treatment for various malignancies such as breast cancer, ovarian cancer, non-small cell lung cancer, and Kaposis sarcoma. Designed as a cytotoxic agent, it inhibits cancer cell proliferation and is recommended for use under strict medical supervision to maximize therapeutic benefits and minimize risks.

Safety and Administration Guidelines

This medication should only be administered intravenously by healthcare professionals with expertise in oncology. Patients must undergo careful monitoring during and after infusion to manage potential side effects, such as nausea and myelosuppression. Individuals with known hypersensitivity to paclitaxel or formulation components must not use MITOTAX.

Storage and Handling Recommendations

To preserve MITOTAXs efficacy, it should be stored between 20C and 25C and kept away from light. Each box contains a single vial for individual patient use, ensuring precise dosing and safety. Always check the expiry date before administration and follow prescribed storage protocols.

FAQs of MITOTAX PACLITAXEL INJECTION:

Q: How should MITOTAX Paclitaxel Injection be administered?

A: MITOTAX is given as an intravenous infusion and must be administered in a clinical setting by an oncology specialist. The dosage and frequency are determined by the physician based on cancer type and patient condition.

Q: What types of cancer is MITOTAX indicated for?

A: MITOTAX is prescribed for ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposis sarcoma, as part of a comprehensive chemotherapy plan.

Q: When should MITOTAX not be used?

A: MITOTAX is contraindicated in individuals hypersensitive to paclitaxel or any other ingredient in its formulation. Always inform your doctor about any known allergies before starting treatment.

Q: Where should MITOTAX Paclitaxel Injection be stored?

A: Store MITOTAX between 20C and 25C (68F to 77F), protected from light. Ensure the vial remains sealed until ready for use and always check the expiration date before administration.

Q: What are the possible side effects of MITOTAX?

A: Common side effects include nausea, vomiting, hair loss (alopecia), myelosuppression, and peripheral neuropathy. Patients should be closely monitored for adverse reactions by healthcare professionals during therapy.

Q: What benefits does MITOTAX offer for cancer treatment?

A: MITOTAX works by inhibiting cell division, helping to control the growth of cancerous cells. It is recognized for its efficacy across several cancer types when administered according to medical guidelines.

Tell us about your requirement